11 results
·
20ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
COBAS CT/NG V2.0 TEST
FDA 510(k)
FDA Class 2
·Microbiology
Gyrus ACMI
FDA UDI
Gyrus ACMI, LLC·00821925014978·CENTERED TORP 6MM LENGTH 0.84 MM DIAMETER DENSE...
VERSITOMIC ACL FLEXIBLE REAMER SYSTEM STERILIZATION TRAY
FDA 510(k)
FDA Class 2
·General Hospital
B-R-A-H-M-S PCT LIA
FDA 510(k)
FDA Class 2
·Microbiology
PELVILACE TO BIOURETHRAL SUPPORT SYSTEM
FDA Adverse Event
Injury
·TISSUE SCIENCE LABORATORIES·Product code FTL·May 24, 2013
4 MOTOR ADVANCE BED
FDA Adverse Event
Malfunction
·HILL-ROM, INC.·Product code FNL·May 31, 2011
9800
FDA Adverse Event
Malfunction
·GE OEC MEDICAL SYSTEMS INC.·Product code JAA·September 3, 2008
Simplexa HSV 1&2 Direct (MOL2150) with Direct Amplification Disc (MOL1451, MOL1452, MOL1455) Model Number: MOL2150, MOL1451, MOL1452, MOL1455
FDA Enforcement
Class I
·Terminated·Focus Diagnostics Inc·April 13, 2016
Simplexa Flu A/B & RSV Direct (MOL2650) with Direct Amplification Disc (MOL1451, MOL1452, MOL1455) Model Number: MOL2650, MOL1451, MOL1452, MOL1455
FDA Enforcement
Class II
·Terminated·Focus Diagnostics Inc·April 13, 2016
Simplexa Group A Strep Direct (MOL2850) with Direct Amplification Disc (MOL1451, MOL1452, MOL1455) Model Number: MOL2850, MOL1451, MOL1452, MOL1455
FDA Enforcement
Class I
·Terminated·Focus Diagnostics Inc·April 13, 2016
Varian brand Clinac, Trilogy, Novalis Tx, Unique, linear accelerators; Model Number: H14, H18, H29, Reference/FSCA Identifier: CP-08881; Product is manufactured and distributed by Varian Medical Systems Inc., Palo Alto, CA. 1) The Varian Low Energy Linear Accelerator is indicated for precision radiotherapy for lesions, tumors and conditions anywhere in the body when radiation treatment i is indicated. (2) The Varian High Energy Linear Accelerator is indicated for stereotactic radiosurgery and precision radiotherapy for lesions, tumors and conditions anywhere in the body when radiation treatment is indicated.
FDA Enforcement
Class II
·Terminated·Varian Medical Systems, Inc. Oncology Systems·September 26, 2012